Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 69,600
+400 (0.58%)
Jul 21, 2026, 3:30 PM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 5.16 trillion as of July 21, 2026. Its market cap has decreased by -47.69% in one year.
Market Cap
5.16T
Enterprise Value
5.16T
Revenue
2.22T
Ranking
n/a
PE Ratio
24.68
Stock Price
69,600.00
ChartMarket Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 5.16T, an increase of 2,127.03%. That is a compound annual growth rate of 13.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 5.16T | -38.49% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 4.72T |
| Hanall Biopharma | 2.50T |
| Celltrion Pharm | 1.69T |
| Daewoong Pharmaceutical | 1.40T |
| GC Biopharma | 1.37T |
| Chong Kun Dang Pharmaceutical | 878.84B |
| DongKook Pharmaceutical | 827.78B |
| Boryung | 680.07B |